U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466160) titled 'A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors' on March 08.
Brief Summary: This study was designed to evaluate the efficacy and safety of 7MW3711 in combination with JS207 in subjects with solid tumor.
Study Start Date: Feb. 11
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Intervention:
DRUG: 7MW3711
7MW3711 will be administered as IV infusion.
DRUG: JS207
JS207 will be administered as IV infusion.
DRUG: Cisplatin
Cisplatin will be administered as IV infusion.
DRUG: Carboplatin
Carboplatin will be administered as IV infusion.
Recruitment Status: RECRUITING
Sponsor: Mabwell (Shanghai)...